Acadia Pharmaceuticals (ACAD) Q3 2026 Earnings

4AugConfirmed
Q3 2025
Q4 2025
Q2 2026
Next
0.02
0.15
0.29
0.42

Details

Expected EPS
0.05738
Actual EPS
N/A
Surprise EPS
-0.06
Surprise Percent
+100%

Description

Acadia Pharmaceuticals (ACAD) will report earnings of for Q3 2026 on August 04, 2026.

0 Comments

Share your thoughts